naloxone hydrochloride
Generic: naloxone hydrochloride
Labeler: hf acquisition co. llc, dba healthfirstDrug Facts
Product Profile
Brand Name
naloxone hydrochloride
Generic Name
naloxone hydrochloride
Labeler
hf acquisition co. llc, dba healthfirst
Dosage Form
INJECTION
Routes
Active Ingredients
naloxone hydrochloride 1 mg/mL
Manufacturer
Identifiers & Regulatory
Product NDC
51662-1239
Product ID
51662-1239_0fcaff2c-afb8-788b-e063-6394a90ade78
Product Type
HUMAN PRESCRIPTION DRUG
Marketing Category
ANDA
Application Number
ANDA072076
Listing Expiration
2026-12-31
Marketing Start
2018-09-03
Pharmacologic Class
Classes
Normalized Code Variants
Searchable formats for this product NDC code
Digits Only
516621239
Hyphenated Format
51662-1239
Supplemental Identifiers
RxCUI
UNII
Resolved Product View
Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.
Resolved Identity
Brand Name
naloxone hydrochloride (source: ndc)
Generic Name
naloxone hydrochloride (source: ndc)
Application Number
ANDA072076 (source: ndc)
Routes
source: ndc
Resolved Composition
Strengths
- 1 mg/mL
Packaging
- 1 SYRINGE, PLASTIC in 1 BOX (51662-1239-1) / 2 mL in 1 SYRINGE, PLASTIC
- 10 POUCH in 1 CASE (51662-1239-3) / 1 mL in 1 POUCH (51662-1239-2)
Packages (2)
Ingredients (1)
Linked Drug Pages (1)
Raw FDA Data
View complete raw FDA NDC JSON payload
{"route": ["PARENTERAL"], "spl_id": "0fcaff2c-afb8-788b-e063-6394a90ade78", "openfda": {"unii": ["F850569PQR"], "rxcui": ["1191250"], "spl_set_id": ["74fc593e-ed47-efae-e053-2991aa0a5997"], "manufacturer_name": ["HF Acquisition Co. LLC, DBA HealthFirst"]}, "finished": true, "packaging": [{"sample": false, "description": "1 SYRINGE, PLASTIC in 1 BOX (51662-1239-1) / 2 mL in 1 SYRINGE, PLASTIC", "package_ndc": "51662-1239-1", "marketing_start_date": "20180903"}, {"sample": false, "description": "10 POUCH in 1 CASE (51662-1239-3) / 1 mL in 1 POUCH (51662-1239-2)", "package_ndc": "51662-1239-3", "marketing_start_date": "20201027"}], "brand_name": "NALOXONE HYDROCHLORIDE", "product_id": "51662-1239_0fcaff2c-afb8-788b-e063-6394a90ade78", "dosage_form": "INJECTION", "pharm_class": ["Opioid Antagonist [EPC]", "Opioid Antagonists [MoA]"], "product_ndc": "51662-1239", "generic_name": "NALOXONE HYDROCHLORIDE", "labeler_name": "HF Acquisition Co. LLC, DBA HealthFirst", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "NALOXONE HYDROCHLORIDE", "active_ingredients": [{"name": "NALOXONE HYDROCHLORIDE", "strength": "1 mg/mL"}], "application_number": "ANDA072076", "marketing_category": "ANDA", "marketing_start_date": "20180903", "listing_expiration_date": "20261231"}